MARIO ROBBINS: Open Payments
NPI 1538151717 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,281 in 210 payments from 17 companies in 2025. Trend: 2023 $3,410 · 2024 $3,792 · 2025 $4,281
Food & beverage: $4,281
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 32 | $779 |
| E.R. Squibb & Sons, L.L.C. | 44 | $695 |
| Otsuka America Pharmaceutical, Inc. | 19 | $461 |
| Alkermes, Inc. | 22 | $435 |
| Lundbeck LLC | 21 | $424 |
| Neurocrine BioSciences, Inc. | 16 | $396 |
| Teva Pharmaceuticals USA, Inc. | 17 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $263 |
| ABBVIE INC. | 13 | $193 |
| Almatica Pharma LLC | 3 | $76 |
Products named: FANAPT, COBENFY, REXULTI, ARISTADA, INGREZZA, UZEDY, CAPLYTA, ABILIFY MAINTENA.
Industry payments across IN — which companies pay providers there.
